These CD11c-dnTGFbRIII transgenic mice express a dominant negative form of the human transforming growth factor, beta receptor II gene under the control of a CD11c (Itgax) promoter. Expression of the transgene is detected by RT-PCR in CD11c-expressing cells, including natural killer (NK) cell and lymphoid/myeloid dendritic cell (DC) subsets. Expression is not detected in natural killer T cells (NKT) cells, T cells or B cells isolated from transgenic mice. Transgenic mice show a selective dysregulation of NK cell homeostasis due to a blockage of transforming growth factor, beta (Tgfb) signalling. Large numbers of NK cells capable of producing considerable levels of interferon gamma (IFN-g) lead to downstream T helper type 1 (TH1) cell polarization.
Dr. Richard A. Flavell, Yale University School of MedicineRead More +
These CD11c-dnTGFβRII transgenic mice express a dominant negative form of the human transforming growth factor, beta receptor II gene under the control of a CD11c (Itgax) promoter. This form of the receptor blocks transforming growth factor, beta (Tgfb) signalling when its expression is sufficiently high to interfere with the assembly of a functional signaling complex consisting of transforming growth factor beta and type II and type I transforming growth factor beta receptors. Expression of the transgene is detected by RT-PCR in CD11c-expressing cells, including natural killer (NK) cell and lymphoid/myeloid dendritic cell (DC) subsets. Expression is not detected in natural killer T cells (NKT) cells, T cells or B cells isolated from transgenic mice. Transgenic mice show a selective dysregulation of NK cell homeostasis due to the blockage of transforming growth factor, beta (Tgfb) signalling. Large numbers of NK cells capable of producing considerable levels of interferon gamma (IFN-g) lead to downstream T helper type 1 (TH1) cell polarization. Mice bearing this transgene are viable and fertile and show no abnormalities in development.
A transgenic vector carrying a CD11c (Itgax) mouse promoter driving the human dnTGFBRIII (Tgfbr2 transforming growth factor, beta receptor II) gene inserted into exon 3 of the rabbit beta globin gene was injected into (C57BL/6 x C3H)F1 hybrid fertilized eggs. The donating investigator reports that this line has been backcrossed more than 10 times to C57BL/6Ncr (see SNP note below).
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, at least 3 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
|Expressed Gene||TGFBR2, transforming growth factor beta receptor II, human|
|Site of Expression|
|Allele Name||transgene insertion 1, Richard A Flavell|
|Allele Type||Transgenic (Dominant negative, Humanized sequence, Inserted expressed sequence)|
|Allele Synonym(s)||CD11c-dnTGFBRII; CD11cdnR; Cd11cdnTGFBR2|
|Gene Symbol and Name||Tg(Itgax-TGFBR2)1Flv, transgene insertion 1, Richard A Flavell|
|Promoter||Itgax, integrin alpha X, mouse, laboratory|
|Expressed Gene||TGFBR2, transforming growth factor beta receptor II, human|
|Strain of Origin||(C57BL/6 x C3H)F1|
|Molecular Note||The human TGFBRIII (Tgfbr2 transforming growth factor, beta receptor II) gene sequence between nucleotides -7 to +573 encoding the extracellular and transmembrane regions of TGFBR2 (dominant negative, dnTGFBR2) was inserted into exon 3 of the rabbit betaglobin gene in the plasmid Itgax promoter vector pDOI-5. The construct was injected into (C57BL/6 x C3H)F1 hybrid fertilized eggs. RT-PCR confirmed expression of dnTGFBR2 in Itgax (CD11c)-expressing cells including subsets of natural killer cell (NK) anddendritic cell (DC) subsets. No expression is detected in NKT cells, T cells or B cells. Expression is sufficient to block TFG beta signaling through the functional receptor exclusively in DCs and NK cells.|
|Mutations Made By|| |
Dr. Richard Flavell, Yale University School of Medicine
|Please inquire about possible genotypes.|
The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided,
their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of
each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders
are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in
order to provide the minimum number of animals, animals will ship within 25 weeks.
The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.